Abstract
Through cDNA array analyses and immunohistochemistry on tissue microarrays, trefoil factor 3 (TFF3) was recently shown to be overexpressed in prostate cancer. The purpose of this study was to test the feasibility of using the levels of trefoil factors as a plasma marker for prostate cancer.
Original language | English |
---|---|
Journal | Clinical Cancer Research |
Volume | 12 |
Issue number | 3 Pt 1 |
Pages (from-to) | 807-812 |
Number of pages | 6 |
ISSN | 1078-0432 |
DOIs | |
Publication status | Published - 2006 |
Keywords
- Aged
- Aged, 80 and over
- Enzyme-Linked Immunosorbent Assay
- Gene Expression Regulation, Neoplastic
- Humans
- Immunohistochemistry
- Male
- Middle Aged
- Peptides
- Prospective Studies
- Prostate-Specific Antigen
- Prostatic Neoplasms
- Sensitivity and Specificity
- Tumor Suppressor Proteins